Literature DB >> 9755260

Selective head cooling in newborn infants after perinatal asphyxia: a safety study.

A J Gunn1, P D Gluckman, T R Gunn.   

Abstract

AIMS: To determine the practicality and safety of head cooling with mild or minimal systemic hypothermia in term neonates with moderate to severe hypoxic-ischemic encephalopathy.
METHODS: Study group infants >/=37 weeks' gestation, who had an umbilical artery pH </=7. 09 or Apgars </=6 at 5 minutes, plus evidence of encephalopathy. Infants with major congenital abnormalities were excluded. TRAIL
DESIGN: Infants were randomized to either no cooling (controls; rectal temperature = 37.0 +/- 0.2 degreesC, n = 10) or sequentially, either minimal systemic cooling (rectal temperature = 36.3 +/- 0.2 degreesC, n = 6) or mild systemic cooling (rectal temperature = 35.7 +/- 0.2 degreesC, n = 6). Head cooling was accomplished by circulating water at 10 degreesC through a coil of tubing wrapped around the head for up to 72 hours. All infants were warmed by servo-controlled overhead heaters to maintain the allocated rectal temperature. The rectal, fontanelle, and nasopharyngeal temperatures were continuously monitored.
RESULTS: From January 1996 to October 1997, 22 term infants were randomized from 2 to 5 hours after birth. All infants showed a metabolic acidosis at delivery, with similar umbilical artery pH in the control group (mean +/- standard deviation, 6.79 +/- 0.25), minimal cooling group (6.98 +/- 0.21), and mild cooling group (6.93 +/- 0.11), and depressed Apgar scores at 5 minutes in the control group (4.5 +/- 2), minimal cooling group, (4.7 +/- 2) and mild cooling group (6.0 +/- 1). In the mild-cooled infants, the nasopharyngeal temperature was 34.5 degreesC during cooling, 1.2 degreesC lower than the rectal temperature. This gradient narrowed to 0.5 degreesC after cooling was stopped. No adverse effects because of cooling were observed. No infants developed cardiac arrhythmias, hypotension, or bradycardia during cooling. Thrombocytopenia occurred in 2 out of 10 controls, 2 out of 6 minimal cooling infants, and 1 out of 6 mild cooling infants. Hypoglycemia (glucose <2.6 mM) was seen on at least one occasion in 2 out of 10 controls, 4 out of 6 minimal cooling infants, and 1 out of 6 mild cooling infants. Acute renal failure occurred in all infants. The metabolic acidosis present in all infants at the time of enrollment into the study progressively resolved despite cooling, even in the mild hypothermia group.
CONCLUSIONS: Mild selective head cooling combined with mild systemic hypothermia in term newborn infants after perinatal asphyxia is a safe and convenient method of quickly reducing cerebral temperature with an increased gradient between the surface of the scalp and core temperature. The safety of mild hypothermia with selective head cooling is in contrast with the historical evidence of adverse effects with greater depths of whole-body hypothermia. This safety study and the strong experimental evidence for improved cerebral outcome justify a multicenter trial of selective head cooling for neonatal encephalopathy in term infants.

Entities:  

Mesh:

Year:  1998        PMID: 9755260     DOI: 10.1542/peds.102.4.885

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  51 in total

1.  Hypoxic-Ischemic Encephalopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.598

Review 2.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Intranasal perfluorochemical spray for preferential brain cooling in sheep.

Authors:  Marla R Wolfson; Daniel J Malone; Jichuan Wu; John Hoffman; Allan Rozenberg; Thomas H Shaffer; Denise Barbut
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 4.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 5.  Ethical issues in neonatal and pediatric clinical trials.

Authors:  Naomi Laventhal; Beth A Tarini; John Lantos
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 6.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

7.  Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy.

Authors:  Seetha Shankaran; Athina Pappas; Abbott R Laptook; Scott A McDonald; Richard A Ehrenkranz; Jon E Tyson; Michelle Walsh; Ronald N Goldberg; Rosemary D Higgins; Abhik Das
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

8.  Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data.

Authors:  A David Edwards; Peter Brocklehurst; Alistair J Gunn; Henry Halliday; Edmund Juszczak; Malcolm Levene; Brenda Strohm; Marianne Thoresen; Andrew Whitelaw; Denis Azzopardi
Journal:  BMJ       Date:  2010-02-09

9.  Neonatal ECMO Study of Temperature (NEST)--a randomised controlled trial.

Authors:  David J Field; Richard Firmin; Denis V Azzopardi; Frances Cowan; Edmund Juszczak; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2010-04-19       Impact factor: 2.125

10.  Volumetric and anatomical MRI for hypoxic-ischemic encephalopathy: relationship to hypothermia therapy and neurosensory impairments.

Authors:  N A Parikh; R E Lasky; C N Garza; E Bonfante-Mejia; S Shankaran; J E Tyson
Journal:  J Perinatol       Date:  2008-11-20       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.